Vaginal health is an essential component of active and healthy aging in women at midlife
and beyond. As a consequence of hormonal deprivation and senescence, the anatomy and …

In this best practice document, we propose recommendations for the use of LASER for
gynecologic and urologic conditions such as vulvovaginal atrophy, urinary incontinence …

Objective: The aim of the study was to compare 6-month efficacy and safety for treatment of
vaginal dryness/genitourinary syndrome of menopause in women undergoing fractionated …

Objectives: To evaluate the long-term efficacy of a second generation of vaginal laser
treatment, the vaginal erbium laser, as a non-ablative photothermal therapy for the …

Introduction The prevalence of urinary incontinence and of other lower urinary tract
symptoms increases after the menopause and affects between 38% and 55% of women …

Purpose This study aimed to clarify the efficacy of intravaginal CO2-laser treatment in
postmenopausal women with genitourinary syndrome of menopause (GSM). Materials and …

Introduction One of the most common adverse events reported by gynecological cancer
survivors with spontaneous or iatrogenic menopause is vulvo-vaginal atrophy (VVA). An …

Background and objective Quality of life preservation after anti-cancer therapy is a major
challenge for breast cancer survivors. Approximately 42–70% of patients who receive …

VIN is a chronic vulval skin disorder characterized by dysplastic changes of the squamous
epithelium. It is a premalignant lesion, although spontaneous regression has been reported …

Background Increasingly, women have sought alternatives to traditional options (lubricants,
estrogen products, and hormone replacement therapy) for unwelcome vaginal changes of …